Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01834612 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
A Phase 1 study, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01834612 is a Phase 1 study that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 20 participants.
The verdict
NCT01834612, a Phase 1 study, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine if a manual blood loss can be detected using the non-invasive blood monitor.
Interventions
- DEVICE CM1500
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-01-07 |
| Est. Completion | 2013-03-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01834612
The ClinicalTrials.gov registry entry for NCT01834612 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zynex Monitoring Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CM1500 is the first listed.
NCT01834612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01834612 about?
NCT01834612 is a clinical study titled "Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw". To determine if a manual blood loss can be detected using the non-invasive blood monitor.
What is the current status of trial NCT01834612?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2013-01-07. Estimated completion is 2013-03-11.
What interventions are being tested in trial NCT01834612?
The interventions under investigation include: CM1500 (DEVICE).
Who is sponsoring clinical trial NCT01834612?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.